CNSP News and Press, CNS Pharmaceuticals Inc. From 05/15/23

Enrollment in ongoing potentially pivotal study evaluating Berubicin for the treatment of GBM continues to rapidly progress toward planned interim analysis, expected in the third quarter of 2023 HOUSTON, TX / ACCESSWIRE / May 15, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or t...

While the treatment of cancer has improved significantly these past decade, brain metastases still have no cure. The clinical need for effective and targeted treatments continues to grow, as more patients are diagnosed with this fatal illness. New research recently discovered a protein found ...

A new study has led to the discovery of gene variants that may play a significant role in handing down glioma from a parent to their child. A glioma is a type of primary brain tumor that stems from glial cells, which support neuron function. Familial glioma usually affects members of the same...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Bettina M. Cockroft, M.D., M.B.A., to its board of directors. Dr. Coc...

Brings over 30 years of significant biopharmaceutical industry experience and proven clinical development and operational expertise across multiple therapeutic disciplines worldwide HOUSTON, TX / ACCESSWIRE / May 8, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"),...

2023-05-04 08:55:15 ET Enviva EVA -50% after Q1 earning release . First Horizon Corporation FHN -43% after merger with TD Bank ends. Sensus Healthcare SRTS -42% after Q1 earning release . PacWest Bancorp PACW -41% on confirming sale talks follow...

2023-05-03 10:01:41 ET Gainers: Aptorum ( APM ) +133% . ImmunoGen ( IMGN ) +123% . Akanda ( AKAN ) +63% . Mersana Therapeutics ( MRSN ) +37% . CNS Pharmaceuticals ( CNSP ) +25% . Losers: Assure ( IONM ) -38% ....

2023-05-03 09:56:57 ET CNS Pharmaceuticals ( NASDAQ: CNSP ) has retained Shareholder Intelligence Services to investigate trading patterns of its stock amidst potential naked short selling . "We have zero tolerance for illegal naked short selling and any other manipulation...

HOUSTON, TX / ACCESSWIRE / May 3, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it is in...

A recent study conducted by researchers at Johns Hopkins has found that a hydrogel administered in mice with glioblastoma cured the illness completely. This finding provides new hope for patients suffering from this aggressive brain cancer, which has an average life expectancy of 15 months. ...